Modular Finance IR Consensus: XVIVO Perfusion – Consensus estimates Q1 2025
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.
Number of contributors: 7 (all of which have been updated or confirmed before the report)
| KPI (MSEK, unless otherwise specified) | Q1 2025E |
| Net sales | 213 |
| Organic growth in local currency (%) | 13.00 |
| Gross profit | 159 |
| EBITDA | 43.2 |
| EBIT | 25.3 |
| Net profit | 23.6 |
| Earnings per share (SEK) | 0.75 |
XVIVO Perfusion’s Q1 report will be released on Thursday, 24 April 2025 at 07.30 CEST.